Asthma/COPD drug being discontinued.
Do you have asthma or COPD? If so and you have been using the inhaler called Foradil, take note.
The Food and Drug Administration (FDA) announced that Foradil Aerolizer (contains formoterol fumarate) and produced by Merck has been discontinued. The decision to discontinue Foradil was business-related and not due to safety or effectiveness.
It is anticipated that the inventory of Foradil will be exhausted and no longer distributed around January 2016, although inventory may be depleted earlier.
Foradil Aerolizer is indicated as “add on” treatment for the daily treatment/control of asthma; maintenance treatment of COPD; and prevention of exercise-induced bronchospasm (EIB). Foradil is a long-acting bronchodilator (LABA) and although will not be available alone in its own inhaler, it continues to be available as 1 of the 2 medications found in Symbicort® and Dulera® inhalers. The other medication in these medications is a corticosteroid which is a key medication in controlling the inflammation of asthma.
At Family Allergy & Asthma Care of Montana, we keep you up to date on the medications available for treating asthma. When one door closes, another one opens! (stay tuned for new medications for asthma that are being released).
For more information visit FDA.gov.